HDL THERAPEUTICS, INC.
HDL-raising therapeutics for atherosclerosis treatment
- Sector
- Biotech
- Headquarters
- VERO BEACH, FL
- Founded
- 2013
- Latest Form D
- $1.3M, Jul 2023
- Total capital
- $12.1M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $12.1M
- 6 Form D · last Jul 2023
- 40 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 5
- 35 pending · first 2020
- Rank in peer group#269 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 6th filing$1.3M
- Private capital raisedForm D · SEC · 5th filing$3.4M
- Private capital raisedForm D · SEC · 4th filing$3M
- Private capital raisedForm D · SEC · 3rd filing$1.5M
- Private capital raisedForm D · SEC · 2nd filing$2M
- Private capital raisedForm D · SEC · 1st filing$925K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#269 · top 19%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Bryan BrewerExecutive Officer, DirectorNamed in SEC Form D filings
- Dane AndreeffDirectorNamed in SEC Form D filings
- Gregg SessaDirectorNamed in SEC Form D filings
- Michael MatinExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 5 granted of 40- PendingMethods for Preserving and Administering Pre-Beta High Density Lipoprotein Having a Predetermined Minimum Level of DegradationUSPTOApplication 18411248
- GrantedMethods for Preserving and Administering Pre-Beta High Density Lipoprotein Having a Predetermined Minimum Level of DegradationUSPTOUS 11,903,965
- PendingMethods for Treating Cholesterol-Related DiseasesUSPTOApplication 17805839
Show all 40 patent records
- Methods for Preserving and Administering Pre-Beta High Density Lipoprotein Having a Predetermined Minimum Level of DegradationMay 9, 2024 · Application 18411248Pending
- Methods for Preserving and Administering Pre-Beta High Density Lipoprotein Having a Predetermined Minimum Level of DegradationFeb 20, 2024 · US 11,903,965Granted
- Methods for Treating Cholesterol-Related DiseasesNov 9, 2023 · Application 17805839Pending
- Methods and Systems for Prophylactically Preventing, Slowing the Progression of, or Treating Cerebral Amyloid Angiopathy, Alzheimer's Disease, and/or Acute StrokeMay 4, 2023 · Application 18045920Pending
- Systems for Removing Air from the Fluid Circuits of a Plasma Processing SystemAug 2, 2022 · US 11,400,188Granted
- Systems And Methods For Reducing Low Attenuation Plaque And/or Plaque Burden In PatientsJun 30, 2022 · Application 17571225Pending
- Systems and Methods for Treating Patients Infected with SARS-COV-2Sep 16, 2021 · Application 17191569Pending
- Methods for Preserving and Administering Pre-Beta High Density Lipoprotein Having a Predetermined Minimum Level of DegradationJun 15, 2021 · US 11,033,582Granted
- Systems and Methods for Priming Fluid Circuits of a Plasma Processing SystemJun 8, 2021 · US 11,027,052Granted
- Multi-Modal Plasma Delipidation SystemsApr 29, 2021 · Application 17012410Pending
- Methods for Preserving and Administering Pre-Beta High Density Lipoprotein Extracted from Human PlasmaNov 3, 2020 · US 10,821,133Granted
- Methods for Treating Lipid-Related Diseases Including Xanthomas, Carotid Artery Stenoses, and Cerebral AtherosclerosisJun 4, 2020 · Application 16698193Pending
- Methods for Prophylactically Preventing, Slowing the Progression of, or Treating Cerebral Amyloid Angiopathy, Alzheimer's Disease and/or Acute StrokeDec 19, 2019 · Application 16409543Pending
- Methods for Prophylactically Preventing, Slowing the Progression of, or Treating Alzheimer's DiseaseMar 7, 2019 · Application 15909765Pending
- Methods for Treating Cholesterol-Related DiseasesJan 24, 2019 · Application 15876808Pending
- Component Kits For Use In A Plasma Delipidation SystemDec 13, 2018 · Application 16003926Pending
- Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid ContentJun 22, 2017 · Application 15454263Pending
- Systems And Methods For Treating Patients Infected With SARS-COV-2Application 62990818Pending
- Systems And Methods For Treating Patients Infected With SARS-COV-2Application 62986136Pending
- Methods for Prophylactically Preventing, Slowing the Progression of, or Treating Cerebral Amyloid Angiopathy, Alzheimer's Disease and/or Acute StrokeApplication 63262423Pending
- Methods For Treating Lipid-related Diseases Including Xanthomas, Carotid Artery Stenoses, And Cerebral AtherosclerosisApplication PCTUS2019063659Pending
- Systems And Methods For Reducing Low Attenuation Plaque And/or Plaque Burden In PatientsApplication 63296928Pending
- Methods For Prophylactically Preventing, Slowing The Progression Of, Or Treating Cerebral Amyloid Angiopathy, Alzheimer's Disease And/or Acute StrokeApplication PCTUS2019031832Pending
- Systems And Methods For Reducing Low Attenuation Plaque And/or Plaque Burden In PatientsApplication PCTUS2022011677Pending
- Methods For Preserving And Administering Pre-beta High Density Lipoprotein Extracted From Human PlasmaApplication PCTUS2018066389Pending
- Methods for Treating Cholesterol Related DiseasesApplication 62773388Pending
- Methods And Systems For Prophylactically Preventing, Slowing The Progression Of, Or Treating Cerebral Amyloid Angiopathy, Alzheimer's Disease And/or Acute StrokeApplication PCTUS2022077947Pending
- Systems And Methods For Priming Fluid Circuits Of A Plasma Processing SystemApplication PCTUS2018062339Pending
- Methods for Treating Cholesterol-Related Diseases Using Administered Solutions Having Increased Pre-Beta HDL ParticlesApplication 16046830Pending
- Methods for Prophylactically Preventing, Slowing the Progression of, or Treating Cerebral Amyloid Angiopathy, Alzheimer's Disease and/or Acute StrokeApplication 62700804Pending
- Methods for Prophylactically Preventing, Slowing the Progression of, or Treating Cerebral Amyloid Angiopathy, Alzheimer's Disease and/or Acute StrokeApplication 62670615Pending
- Methods For Prophylactically Preventing, Slowing The Progression Of, Or Treating Alzheimer's DiseaseApplication PCTUS2018020502Pending
- Methods For Treating Cholesterol-related DiseasesApplication PCTUS2018014671Pending
- Methods for Treating Cholesterol-Related DiseasesApplication 62611098Pending
- Systems And Methods For Causing Regression Of Arterial PlaqueApplication 62589919Pending
- Methods for Treating Cholesterol-Related DiseasesApplication 62537581Pending
- Method for Treating Cholesterol-Related DiseasesApplication 62516100Pending
- Method for Treating Familial HypercholesterolemiaApplication 62465262Pending
- Methods for Treating Lipid-Related Dysfunction in Lupus PatientsApplication 63135001Pending
- Method for Treating Familial HypercholesterolemiaApplication 62449416Pending
Related companies, and why
- Convelo Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Octagon Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- nferenceSimilar federal contract value in Biotech · null in contracts
- Encellin, Inc.Similar federal contract value in Biotech · null in contracts
- MACROGENICS INCSimilar federal contract value in Biotech · null in contracts
- Akebia Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .